"For patients who have larger tumors but can't undergo surgery, this approach could be more effective," interventional radiologist Yolanda Bryce, M.D. said Getty Breast cancer patients who were ...
Cryoablation involves applying extremely cold gas or liquid to an area of cancerous or abnormal tissue. The treatment freezes and destroys the cells. Doctors use cryoablation to treat tumors on the ...
May 10, 2004 — Cryoablation for early-stage breast cancer is safe and well tolerated, according to the results of a multi-institutional pilot study published in the May issue of the Annals of Surgical ...
CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...
Ice could be the next frontier in breast cancer therapy, according to new research from Memorial Sloan Kettering Cancer Center in New York. In breast cancer patients, cold therapy was shown to be ...
For patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer by freezing – called cryoablation – yields a lower-risk of ...
Nephron-sparing surgery for small-to-medium sized renal tumors has undoubtedly become a standard of patient management in the 21 st century. The recent trends toward nephron sparing stem from an ...
ORLANDO -- Cryoablation without excision for low-risk, early-stage breast cancer may be an option for women over 60, 5-year follow-up results from the ICE3 trial showed. At a mean follow-up of 54.2 ...
Cryoablation uses extreme cold to destroy heart tissue that causes an irregular heartbeat, intending to restore a regular heart rhythm. Doctors may suggest cryoablation if other treatments do not work ...
"ProSense® offers the first new innovation in the treatment of women aged 70 and above with low-risk early-stage breast cancer in decades. We are proud to deliver a significant advancement and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results